207_Combined course Presentations

National or institutional molecular screening programs in breast cancer and other advanced solid tumors predictive biomarker

Institution or National Program

Platform

Cancer(s)

Archival vs Biopsy

Timeframe

Additional Details

Cancer Research UK Unknown

Breast, Melanoma, Prostate, Ovarian, CRC, and NSCLC

Archival

4Q2011

Stratified Medicine Program. To include 9,000 patients in 7 cancer centres across UK. MOSCATO (phase I; 600 patients) and SAFIR (breast; 400 patients) 1200 patients over 3 years with 2000 genes/patient

Institut Gustav Roussy

aCGH

Breast, Phase I

Biopsy

Ongoing

Sanger

Dutch (Amsterdam, Rotterdam, Utrecht)

Targeted exome sequencing (?HiSeq)

Phase I

Biopsy

Ongoing